ArticleScientific reports2025

Repurposing antibacterial drugs identifies ridinilazole and CRS3123 as promising candidates against vancomycin-resistant enterococci.

Somaia M Abdelmegeed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.